Citation Impact
Citing Papers
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
2016 Standout
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement
2008
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
2004
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Is Botulinum Neurotoxin Type A (BoNT-A) a Novel Therapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement? A Review of the Literature
2008
Long‐term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5α‐reductase inhibitor dutasteride: results of 4‐year studies
2005
MR‐guided prostate interventions
2008
Emerging targets in the AKT pathway for treatment of androgen-independent prostatic adenocarcinoma
2002
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
1999
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines)
2004
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
1996
Epidemiology of Prostate Cancer
2019 Standout
The natural history of benign prostatic hyperplasia: what have we learned in the last decade?
2000
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Organic and inorganic contaminants removal from water with biochar, a renewable, low cost and sustainable adsorbent – A critical review
2014 Standout
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
2000
5α-reduced C21 steroids are substrates for human cytochrome P450c17
2003
Biological roles of glycans
2016 Standout
Serenoa repens for benign prostatic hyperplasia
2002
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial
1998
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
Municipal solid waste characterization and quantification as a measure towards effective waste management in Ghana
2015 Standout
Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia
1998
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
2009
Alpha-Blocker Therapy Can Be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5α-Reductase Inhibitor Dutasteride
2003
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
2002
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
Hormesis and medicine
2008
Sustained-Release Alfuzosin, Finasteride and the Combination of Both in the Treatment of Benign Prostatic Hyperplasia
1998
Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial
2003
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
The hallmarks of cancer
2012 Standout
Prostate Cancer Susceptibility Genes: Many Studies, Many Results, No Answers
2001
Serenoa repensfor benign prostatic hyperplasia
2009
Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan
2003
5α-Reductase inhibitor treatment of prostatic diseases: background and practical implications
2008
Targeting Wide-Range Oncogenic Transformation via PU24FCl, a Specific Inhibitor of Tumor Hsp90
2004 StandoutNobel
Cancer as an evolutionary and ecological process
2006 Standout
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the randomized, double‐blind Combination of Avodart and Tamsulosin (CombAT) trial
2011
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate
2007
Motor recovery after stroke: a systematic review
2009 Standout
Municipal solid waste characterizations and management strategies for the Lower Rio Grande Valley, Texas
2007
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Biochar as a sorbent for contaminant management in soil and water: A review
2013 Standout
Conversion of sewage sludge to clean solid fuel using hydrothermal carbonization: Hydrochar fuel characteristics and combustion behavior
2013 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Hydrothermal carbonization of biomass residuals: a comparative review of the chemistry, processes and applications of wet and dry pyrolysis
2010
Basic anatomical and physiological data for use in radiological protection: reference values
2002 Standout
Morbidity, Mortality and Early Outcome of Transurethral Resection of the Prostate: A Prospective Multicenter Evaluation of 10,654 Patients
2008
Botulinum Neurotoxin Type A for the Treatment of Benign Prostatic Hyperplasia: Randomized Study Comparing Two Doses
2012
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Is transurethral resection of the prostate still justified?
1999
Medical Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
2009
A comparison of randomised controlled trials in health and education
2005
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Environmental Externalities of Geological Carbon Sequestration Effects on Energy Scenarios
2004 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Prevention of Hormone-Related Cancers: Prostate Cancer
2005
Burn or Bury? A Social Cost Comparison of Final Waste Disposal Methods
2003
Information and the decision to recycle: results from a survey of US households
2009
TRANSURETHRAL ETHANOL INJECTION THERAPY FOR PROSTATIC HYPERPLASIA: 3-YEAR RESULTS
2004
Medroxyprogesterone Acetate and Dexamethasone Are Competitive Inhibitors of Different Human Steroidogenic Enzymes1
1999
A comparative review of biochar and hydrochar in terms of production, physico-chemical properties and applications
2015 Standout
Finasteride for benign prostatic hyperplasia
2010
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Hereditary Prostate Cancer: Clinical Aspects
2002
UROLOGIC DISEASES IN AMERICA PROJECT: BENIGN PROSTATIC HYPERPLASIA
2005
A review of the socio-economic advantages of textile recycling
2019 Standout
Works of Patrick Walsh being referenced
Accuracy of In-Vivo Assessment of Prostatic Volume by MRI and Transrectal Ultrasonography
1992
Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families
2001
The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
1998
Decision maker's guide to solid waste management
1995